|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
10/24/2023 |
$0.45 |
$0.49 |
$0.37 |
$0.43 |
423.30K | 10/25/2023 |
$0.44 |
$0.56 |
$0.43 |
$0.53 |
430.10K | 10/26/2023 |
$0.54 |
$0.58 |
$0.50 |
$0.54 |
355.10K | 10/27/2023 |
$0.53 |
$0.58 |
$0.53 |
$0.53 |
200.60K | 10/30/2023 |
$0.57 |
$0.58 |
$0.48 |
$0.51 |
479.70K |
|
Catalyst Biosciences, together with its subsidiary, is a biopharmaceutical company focused on development and commercialization of Hydronidone for the treatment of NASH (nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease) in the U.S. Hydronidone is being evaluated for the treatment of liver fibrosis associated with a spectrum of chronic liver diseases. A Phase 1 clinical trial of Hydronidone has been completed in the U.S. and generated pharmacokinetic, safety and tolerability data of single and multiple ascending doses of Hydronidone in U.S. healthy subjects. | |
|
CBIO (CBIO) has the following price history information. Looking back at CBIO historical stock prices for the last five trading days, on October 24, 2023, CBIO opened at $0.45, traded as high as $0.49 and as low as $0.37, and closed at $0.43. Trading volume was a total of 423.30K shares. On October 25, 2023, CBIO opened at $0.44, traded as high as $0.56 and as low as $0.43, and closed at $0.53. Trading volume was a total of 430.10K shares. On October 26, 2023, CBIO opened at $0.54, traded as high as $0.58 and as low as $0.50, and closed at $0.54. Trading volume was a total of 355.10K shares. On October 27, 2023, CBIO opened at $0.53, traded as high as $0.58 and as low as $0.53, and closed at $0.53. Trading volume was a total of 200.60K shares. On October 30, 2023, CBIO opened at $0.57, traded as high as $0.58 and as low as $0.48, and closed at $0.51. Trading volume was a total of 479.70K shares.
CBIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into CBIO shares, starting with a $10,000 purchase of CBIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
10/30/2023 |
|
Start price/share: |
$459.90 |
|
End price/share: |
$0.51 |
|
Starting shares: |
21.74 |
|
Ending shares: |
257.07 |
|
Dividends reinvested/share: |
$61.41 |
|
Total return: |
-98.69% |
|
Average Annual Total Return: |
-36.55% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$131.04 |
|
Years: |
9.53 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
10/30/2023 |
|
Start price/share: |
$459.90 |
|
End price/share: |
$0.51 |
|
Dividends collected/share: |
$61.41 |
|
Total return: |
-86.54% |
|
Average Annual Total Return: |
-18.98% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,345.85 |
|
Years: |
9.53 |
|
|
|
Date |
Close |
10/24/2023 | $0.43 | 10/25/2023 | $0.53 | 10/26/2023 | $0.54 | 10/27/2023 | $0.53 | 10/30/2023 | $0.51 |
|
|